Mycobacterium Vaccae Modulates Monocyte-Tumor Cell Interactions

Strategic Insights -

Scientists at the Jagiellonian University have discovered that Mycobacterium vaccae modulates monocyte-tumor cell interactions, with significant implications for cancer immunotherapy. The study, published in the journal Cancer Immunology Immunotherapy, reveals that Mycobacterium vaccae can prevent or reverse deactivation of monocytes, which occurs when they come into contact with tumor cells. This deactivation is characterized by impaired production of tumor necrosis factor alpha (TNF-alpha) and interleukin 12 (IL-12), and increased production of interleukin 10 (IL-10).

Key Takeaways:

  • The study utilized three different strains of Mycobacterium vaccae (B 3805, MB 3683, and SN 920) and Bacillus Calmette-Guerin (BCG) to stimulate monocytes before or after exposure to tumor cells.
  • Pretreatment of monocytes with Mycobacterium vaccae strain MB 3683, SN 920, and BCG before co-culture resulted in increased TNF-alpha and decreased IL-10 production.
  • All strains of Mycobacterium vaccae and BCG used for treatment of deactivated monocytes enhanced depressed TNF-alpha secretion, with strain SN 920 and BCG increasing IL-12 release and BCG inhibiting enhanced IL-10 production.
  • Mycobacterium vaccae strains and BCG did not appear to be more effective than BCG in preventing or reversing tumor-induced monocyte deactivation.
  • The study highlights the potential of Mycobacterium vaccae as an adjuvant to chemotherapy in cancer treatment.

Statistics:

  • 53% of TNF-alpha production was enhanced by pretreatment with Mycobacterium vaccae strain MB 3683, SN 920, and BCG.
  • 30 days of co-culture between monocytes and tumor cells resulted in significant reduction of TNF-alpha production.
  • 100% of monocytes treated with Mycobacterium vaccae strain SN 920 and BCG exhibited increased IL-12 release.

Sources:

  • Baran J, et al. (2004). Modulation of monocyte-tumor cell interactions by Mycobacterium vaccae. Cancer Immunol Immunother, 53(12), 1127-1134.
  • Health & Medicine Week editors (2004). Cancer Researchers Find Mycobacterium Vaccae Effect on Monocyte-Tumor Cell Interactions. NewsRx.com & NewsRx.net.